Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stage IV Squamous Cell Lung Carcinoma

Known as: Stage IV Squamous Cell Carcinoma of Lung, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Metastatic Squamous Cell Carcinoma of Lung 
Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with… Expand
National Institutes of Health

Related topics

Related topics

24 relations
Bronchial Epithelial CellBronchial treeChestChromosome 13q deletion
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Aftermath of induced inflammation: acute periaortitis due to nivolumab therapy
A 57-year-old man with medical history of left upper lobe metastatic squamous cell carcinoma of lung and seizures due to brain… Expand
Is this relevant?
2016
2016
Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy: A Report From the US Food and Drug Administration.
IMPORTANCE Metastatic squamous non-small-cell lung cancer (SQ NSCLC) is a serious and life-threatening malignant condition with… Expand
  • table 1
  • table 2
Is this relevant?
2016
2016
Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion
Nivolumab, a programmed death 1 (PD1) inhibitor, belongs to a family of drugs known as immune checkpoint inhibitors that share a… Expand
  • figure 1
Is this relevant?
2015
2015
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.
IMPORTANCE The SQUIRE trial demonstrated that adding necitumumab to chemotherapy for patients with metastatic squamous cell lung… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2014
2014
Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naïve patient: A report of three cases
The purpose of the present study was to report cases of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-na… Expand
  • table I
  • figure 1
Is this relevant?
2012
2012
Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
BACKGROUND We previously identified amplification of the fibroblast growth factor receptor 1 gene (FGFR1) as a potential… Expand
Is this relevant?
2009
2009
Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.
In this study, typing of human papilloma virus (HPV) was performed in squamous cell carcinomas of the lung (n=26) as well as… Expand
Is this relevant?
2008
2008
Squamous cell lung carcinoma metastatic to the breast.
Secondary malignancy metastatic to the breast is uncommon with an incidence of 0.5% to 3% of patients with extramammary… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1996
1996
A prospective study of pulmonary function in patients receiving mitomycin.
Mitomycin is a chemotherapeutic agent that is used to treat a variety of solid tumors. Pulmonary toxic reactions from this agent… Expand
Is this relevant?
1989
1989
Reflex sympathetic dystrophy associated with squamous cell carcinoma of the lung.
Reflex sympathetic dystrophy was the presenting feature in an otherwise occult case of non-metastatic squamous cell carcinoma of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE